Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multihaler versus Seretide Accuhaler systemic effects study in pre-pubertal children with mild asthma
2005-005828-14Phase 3Completed
- Sponsor
- Neolab Ltd
- Start
- Jan 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate and salmeterol in asthma (2 arms), sponsored by Neolab Ltd. Primary endpoints: Short-term linear growth and Hypothalamic-pituitary-adrenal axis function. Started Jan 2006; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-005828-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005828-14.